Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-001447-37Phase 3Active
Phase 3, randomised, single-blind trial in chronic hand dermatitis (CHE) comparing Oral alitretinoin with Oral azathioprine (2 arms). Primary endpoint: Treatment response at 24 weeks. Started Jun 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-001447-37.